![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Cmic Cmo Co., Ltd. Shimada Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Tranexamic acid, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-027 - Rev 03
This Chemical Type CEP, issued on March 04, 2010, remains in force until December 07, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 875 associated with this CEP further emphasizes